Bioinformation Therapy for Breast Cancer
Bioinformation Therapy for Breast Cancer
The aim of this study is the synergistic effect of cancer ablation and life information
 rehabilitation therapy on unresectable breast cancer.
By enrolling patients with unresectable breast cancer adapted to enrolled criteria, this
 study will document for the first time the synergistic effect of cancer ablation and life
 information rehabilitation therapy. The efficacy will be evaluated according to local relief
 degree, progress free survival (PFS) and overall survival (OS).
Inclusion Criteria:

 -  All standard therapies have failed according to NCCN guidelines or the patient refuses
 standard therapies

 -  Body tumor 1-6, with at least one tumor length > 2 cm

 -  KPS ≥ 70, lifespan > 6 months

 -  Platelet count ≥ 80×109/L，white blood cell count ≥ 3×109/L, neutrophil count ≥
 2×109/L, hemoglobin ≥ 80 g/L

 Exclusion Criteria:

 -  Patients with cardiac pacemaker

 -  Patients with brain metastasis

 -  Patients with grade 3 hypertension or diabetic complication, severe cardiac and
 pulmonary dysfunction